The inhibitory potential of TN14003 a CXCR4 peptide antagonist has been previously studied in inhibiting breast cancer metastasis [12] and inhibiting the migratory and invasive ability of human pancreatic cancer cell lines [24]. Here, CXCR4 is linked to breast carcinoma.